Homepage
AGING Analysis Report
Jun 18, 2026
8 days ago · 93% complete · +8 refreshed
Archived report · generated Jun 3, 2026 · 6:57 PM · models: linear-pipeline · cost: $0.300
Back to latest →

NIKE, Inc.

NKE NYSE Categories PDF
Consumer Cyclical · Apparel - Footwear & Accessories
Beaverton, OR 97005-6453, United States IPO 1980 investors.nike.com Updated Jun 3, 6:13pm
Price
$43.81
Market Cap
$64.8B
Employees
79,400
Beta
1.12
Avg Volume
22,731,680
CEO
Elliott J. Hill
Business Description

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. In addition, it sells a line of performance equipment and accessories comprising bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. The company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel. Additionally, it licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Business History
Generated: Jun 3, 2026 6:54pm
Price Overview
Last updated: Jun 3, 2026 6:51pm (23d ago)
$43.81
+0.08 (+0.18%)
Day Range
$43.16 – $43.99
52-Week Range
$41.35 – $80.17
50-Day MA
$45.39
200-Day MA
$60.73
Volume
18,777,926.00
Analyst Price Targets
Low $35.00
Consensus $68.71
High $110.00
(158 analysts)
Share Structure
Outstanding 1,478,375,505.00
Float 1,168,997,914.00
Free Float 79.1%
Normal free float — 79.1% of shares trade freely, ~20.9% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Last updated: Jun 3, 2026 6:57pm (23d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 3, 2026 6:57pm (23d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
Industry comparison last run: Jun 18, 2026 10:18pm
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
28.80
Stock Price: $43.81
EPS (Diluted): 2.17
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
6.81
Stock Price: $43.81
Total Equity: $13.21B
Shares: 1,487,600,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
20.80
Market Cap: $64.77B
Total Debt: $7.97B
Cash: $7.46B
EBITDA: $4.51B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$93.5B
Market Cap: $64.77B
Total Debt: $7.97B
Cash: $7.46B
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
42.7%
Gross Profit: $19.79B
Revenue: $46.31B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
8.0%
Operating Income: $3.70B
Revenue: $46.31B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
7.0%
Net Income: $3.22B
Revenue: $46.31B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
16.4%
Net Income: $3.22B
Total Equity: $13.21B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
7.9%
Operating Income: $3.70B
Tax Rate: 17.1%
Equity: $13.21B
Total Debt: $7.97B
Cash: $7.46B
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
2.21
Current Assets: $23.36B
Current Liabilities: $10.57B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.60
Short-Term Debt: $5.00M
Long-Term Debt: $7.96B
Total Debt: $7.97B
Total Equity: $13.21B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$31.13
Revenue: $46.31B
Shares: 1,487,600,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$8.88
Total Equity: $13.21B
Shares: 1,487,600,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$2.20
Operating CF: $3.70B
CapEx: -$430.00M
Shares: 1,487,600,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
2.6%
Last Dividend: N/A
Stock Price: $43.81
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $3.22B
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 18, 2026 10:18pm
Compares NKE against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Advanced Analysis Forensic deep-dive · three lenses
Three separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-06-18 22:24:21
Delvantic - Cairn AI
Quality — wait for a dip, starter only 7/10
Great franchise (+11 quality) at a fair-not-cheap price (-20 value) — I want to own this, but not at $45.
The cruxWhether the FY25 margin collapse (15.6%→8.0% op margin) is a transient reset or a structural step-down — the entire deserved-value range pivots on that one question.
Forensic checks Derived mechanically from NKE's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionShare Count Shrinking
Earnings QualityHigh Earnings Quality
The three lensesswitch a tab for its full read — score + evidence
Company Quality
+11
Strong
edge √Σ 135 · risk √Σ 124 · conf 7/10

Nike remains a structurally high-quality franchise: $9.15B liquid cash, net cash positive ($1.19B), Altman Z of 3.71, and earnings quality that ties out cleanly (OCF/NI 1.12x, accruals -1.7%, Beneish -2.39). Capital allocation is shareholder-friendly — diluted shares fell from 1.61B (2021) to 1.49B (2025), a ~2% CAGR shrink, and buybacks dwarf SBC at ~493%. SBC is a modest 1.5% of revenue. This is the profile of a mature, self-funding compounder that does not need external capital.

But the operating trajectory is the problem. Revenue peaked at $51.36B in 2024 and fell to $46.31B in 2025 (-9.8%), essentially back to 2022 levels. Worse, operating margin collapsed from 15.6% (2021) → 12.3% (2024) → 8.0% (2025), and net income halved from $5.70B to $3.22B in a single year. Gross margin also slipped to 42.7%, the lowest in the window. FCF dropped from $6.62B to $3.27B (-51%). That is not noise — that is a step-change in earnings power, likely reflecting brand/innovation issues, channel reset (DTC pullback), and inventory/promotion pressure.

The offset: insider behavior is genuinely encouraging. Multiple directors made open-market P-purchases in April 2026 (Hill $1.0M, Cook $1.1M, Swan $500K, Rogers $173K) — directors don't buy on the open market casually. Combined with the durable brand moat and clean books, this looks like a quality franchise going through a real but likely fixable downcycle, not a structurally broken business.

Strengths 5
m70
Fortress balance sheet & self-funding
$9.15B liquid cash, $1.19B net cash, Altman Z 3.71 (safe). Generates positive FCF every year in the window; zero dependence on external capital.
m65
Pristine earnings quality
OCF/NI 1.12x, accruals -1.7% of assets, Beneish M -2.39. Reported earnings are backed by cash; no manipulation flags in five years of data.
m60
Genuine per-share value concentration
Diluted shares 1.61B → 1.49B (-7.5% over 4 years, ~2% CAGR). Buyback/SBC ratio of 493% means dilution is being aggressively neutralized, not hidden.
m55
Director open-market buying cluster
In April 2026, directors Hill ($1.0M), Cook ($1.1M), Swan ($500K), and Rogers ($173K) all made P-purchases on the open market — an unambiguous insider conviction signal during the downturn.
m50
Durable brand moat (inferred)
Despite the FY25 slump, Nike still generated $46.3B revenue at 42.7% gross margin — pricing power and global scale that very few apparel businesses replicate.
Concerns 4
m80
Operating margin collapse
Op margin fell 15.6% → 14.3% → 11.5% → 12.3% → 8.0%. Net income halved ($5.70B → $3.22B) in FY25. This is a structural earnings-power degradation, not a one-time charge unless proven otherwise.
m65
Revenue went backwards
Revenue fell from $51.36B (2024) to $46.31B (2025), erasing two years of growth. For a mature consumer franchise, an absolute revenue decline of ~10% signals real brand/demand issues.
m60
FCF cut in half
FCF dropped from $6.62B (2024) to $3.27B (2025). Buyback capacity at this run-rate is materially constrained vs. prior years.
m35
Gross margin slipped to multi-year low
GM 42.7% in FY25 vs. 46.0% in FY22 — suggests promotional pressure, inventory clearance, or input/FX headwinds that may not fully reverse.
This is a high-quality business going through a real operational stumble, not a broken one. The accounting is clean, the balance sheet is a fortress, share count is genuinely shrinking, and directors are putting real personal money in at current levels — that combination almost never coexists with a business in terminal decline. But I'm not going to pretend the operating numbers are fine: revenue down 10%, op margin halved to 8%, FCF cut in half. The franchise quality is intact; the execution quality has cracked. I grade it Strong rather than Fortress because durable brands can still destroy a couple years of earnings power before they fix themselves, and the data doesn't yet show the fix.
Verify before trusting this (7)
  • Whether the FY25 op margin collapse to 8% includes one-time restructuring/impairment charges or reflects a clean run-rate
  • Inventory levels and days-of-inventory trend — is the channel cleaned up or still bloated?
  • China region revenue trajectory and whether weakness is region-specific or global
  • DTC vs wholesale mix shift and whether the wholesale rebuild is gaining traction
  • Innovation pipeline / new product cycle commentary from management
  • Whether the dividend + buyback pace is sustainable at $3.27B FCF run-rate
  • Customer/concentration disclosures in the 10-K around key wholesale accounts
Valuation / Mispricing
-20
Fairly Valued
edge √Σ 59 · risk √Σ 79 · conf 6/10
Price $45.20 vs deserved ~$48-52 — roughly 5-10% theoretical upside, well inside the noise band; effectively fair. attractive below $38.00

The e2e synthesis tags NKE as a 'Reasonable Premium,' which lines up with what the tape shows: $45.20 against a deserved value in the high-$40s to low-$50s for a fortress-balance-sheet brand whose operating margins have compressed but whose earnings quality is clean (quality hint = 3, no haircut). On trailing depressed earnings NKE trades around 30x — optically rich — but that's the wrong anchor; on a normalized mid-cycle EBIT closer to historical 13-14% margins, the multiple compresses into the high-teens, which is roughly what a brand of this caliber deserves. So the market isn't euphoric and it isn't panicking — it's pricing a believable recovery.

What has to go right to justify $45: stabilize China, complete wholesale reset without further share loss to On/Hoka/ASICS, and rebuild gross margin ~150-250bps over 2-3 years. None of that is heroic, but none is in the bag either. The bull case (DTC margin recapture + buyback shrinking the float) gets you to ~$55-60; the bear case (structural China + cultural fragmentation) gets you to ~$32-36. Midpoint sits right around spot. That's the textbook definition of fair, not cheap.

I want a real discount to the deserved value before I lean in — the brand quality argues against calling it expensive, but quality you pay full price for is not edge.

Cheap signals 3
m40
Bear case partially priced in
Stock is well off prior highs and the 'fallen angel' framing means consensus already discounts China weakness and DTC reset friction — limits downside vs a name still at peak expectations.
m35
Buyback + insider buying support the floor
Genuine share count shrink and director open-market buying at current levels suggest insiders see deserved value above spot — a soft signal, not a quantified gap.
m25
Clean earnings quality — no haircut needed
Quality hint of 3 means reported numbers are believable; deserved value does not need to be marked down for accounting risk, which is rare in turnaround names.
Rich / priced-in 3
m55
Optical multiple on depressed earnings
At ~30x trailing EPS the headline multiple is demanding; the bull thesis requires margin recovery to validate the price, leaving little cushion if the turnaround slips a year.
m45
No margin of safety to deserved value
Deserved value sits in the high-$40s to low-$50s on normalized margins; $45.20 already captures most of that, so the asymmetry is symmetric, not skewed.
m35
Competitive share loss is structural risk to deserved value
On Running, Hoka, ASICS taking running share could permanently lower normalized margins/growth — if so the deserved value drifts toward the high-$30s, making $45 expensive.
Fairly valued — I don't see edge here. The business is high-quality and the price isn't stupid, but I'm being asked to pay roughly what it's worth for a turnaround that hasn't proven itself. I need this ~15% lower (sub-$38) before the risk/reward genuinely tilts; above $50 I'd be a seller. In between, it's a hold-or-watch, not a table-pound.
Verify before trusting this (5)
  • Forward gross margin guidance and pace of inventory normalization in next 1-2 quarters
  • China revenue trajectory ex-FX and any commentary on local brand competition
  • Wholesale channel re-engagement progress — door count, sell-in vs sell-through
  • Running category share data vs On/Hoka/ASICS to test the structural-decline thesis
  • Updated buyback pace and FCF conversion to confirm capital return capacity
General Sentiment
-49
Headwind
tail √Σ 51 · head √Σ 100 · conf 7/10

The dominant non-fundamental force on NKE is a strong, moderately durable fallen-angel narrative: the market has decided peak Nike is behind it, with the bear story (On, Hoka, ASICS taking cultural share; China structurally impaired; wholesale partners retaliating against DTC) doing more work than the bull story (margin recapture, DTC inflection). Price action confirms it - a -4.9% CAGR and three years of relative underperformance show the tape has been actively de-rating this name regardless of the broader market. With beta 1.12 and consumer-cyclical exposure, a neutral tape with VIX 17 and a slight pullback from highs is a mild incremental drag, not a tailwind.

Tailwinds 2
m45
Analyst tone diverging positive vs narrative
Buy consensus with 37 buys vs 5 sells, $58.45 target (37% upside), and 6 upward revisions this month averaging $49.67 suggest the sell-side sees an earnings-inflection setup the tape does not yet believe. That divergence is a latent positive.
m25
Cult coefficient still medium - brand equity reservoir
Nike retains enough cultural and institutional ownership gravity that the bear story has a floor; capitulation risk is muted relative to a true zero-cult fallen angel.
Headwinds 4
m70
Fallen-angel narrative with bear story winning
Strong-intensity, moderate-durability narrative where the bear case (brand fragmentation to On/Hoka/ASICS, structural China, wholesale backlash) is the live story. Until earnings inflect visibly, this narrative keeps a lid on multiple expansion.
m55
Persistent negative price momentum
-4.9% CAGR and 3yr relative underperformance signal sustained distribution. Momentum-driven flows and trend followers are not friends here, and 'falling knife' optics deter discretionary buyers.
m35
Consumer-cyclical with above-1 beta into a neutral-stressed tape
Beta 1.12 in a Consumer Cyclical name means a market off 1.8% from highs with VIX elevated above 56% of the year amplifies, modestly, into NKE. Not catastrophic, but not the risk-on environment a fallen-angel needs to re-rate.
m30
Higher rates pressure consumer discretionary multiples
10y at 4.46% keeps duration-sensitive consumer multiples capped and gives no macro tailwind to a stock that needs a re-rating catalyst.
Net pressure leans headwind, not strong headwind. The fallen-angel narrative is doing real damage and momentum confirms the tape is still selling rallies, but the bright spot is a clear divergence: analysts are quietly revising up while the story stays bearish, which is often how these setups bottom. With a neutral-not-hostile macro tape, I read this as ongoing sentiment headwind that is closer to exhaustion than acceleration - heavy enough to keep the stock pinned, not heavy enough to crater it from here.
Verify before trusting this (4)
  • Next earnings print - any China stabilization or DTC margin reacceleration could break the fallen-angel narrative
  • Whether sell-side target revisions continue trending up (6 this month is notable) or stall
  • Competitive datapoints from On, Hoka, ASICS - any sign their share gains are decelerating
  • Sector rotation into consumer discretionary or a VIX collapse that would let beaten-down cyclicals run
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Three lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), and General Sentiment (non-fundamental macro/narrative pressure). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Deep Analysis
Last run: Jun 18, 2026 10:21:57 pm

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for Mature Earner companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for Mature Earner companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for Mature Earner companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for Mature Earner companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for Mature Earner companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for Mature Earner companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 3, 2026 6:57pm (23d ago)
Metric 2021 2022 2023 2024 2025
Revenue $44.5B $46.7B $51.2B $51.4B $46.3B
Cost of Revenue $24.6B $25.2B $28.9B $28.5B $26.5B
Gross Profit $20.0B $21.5B $22.3B $22.9B $19.8B
Operating Expenses $13.0B $14.8B $16.4B $16.6B $16.1B
Operating Income $6.9B $6.7B $5.9B $6.3B $3.7B
Net Income $5.7B $6.0B $5.1B $5.7B $3.2B
EBITDA $7.7B $7.5B $6.8B $7.2B $4.5B
EPS $3.64 $3.83 $3.27 $3.76 $2.17
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 3, 2026 6:51pm (23d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $9.9B $8.6B $7.4B $9.9B $7.5B
Total Current Assets $26.3B $28.2B $25.2B $25.4B $23.4B
Total Assets $37.7B $40.3B $37.5B $38.1B $36.6B
Current Liabilities $9.7B $10.7B $9.3B $10.6B $10.6B
Long-Term Debt $9.4B $8.9B $8.9B $7.9B $8.0B
Total Liabilities $25.0B $25.0B $23.5B $23.7B $23.4B
Total Equity $12.8B $15.3B $14.0B $14.4B $13.2B
Retained Earnings $3.2B $3.5B $1.4B $965.0M -$727.0M
Cash Flow (Annual)
Last updated: Jun 3, 2026 6:57pm (23d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $6.7B $5.2B $5.8B $7.4B $3.7B
Capital Expenditure -$695.0M -$758.0M -$969.0M -$812.0M -$430.0M
Free Cash Flow $6.0B $4.4B $4.9B $6.6B $3.3B
Acquisitions (net) $0 $0 $0 $0 $0
Debt Repayment
Dividends Paid
Stock Buybacks -$608.0M -$4.0B -$5.5B -$4.3B -$3.0B
Net Change in Cash $1.5B -$1.3B -$1.1B $2.4B -$2.4B
Analyst Estimates (Annual)
Last updated: Jun 3, 2026 6:51pm (23d ago)
Metric 2027 2028 2029 2030
Revenue $46.5B
$45.0B – $48.2B
$48.6B
$48.5B – $48.6B
$52.3B
$52.1B – $52.6B
$58.3B
$56.2B – $60.2B
EBITDA $6.5B
$6.3B – $6.8B
$6.8B
$6.8B – $6.8B
$7.4B
$7.3B – $7.4B
$8.2B
$7.9B – $8.5B
Net Income $2.7B
$2.3B – $3.4B
$3.5B
$2.1B – $5.7B
$4.1B
$3.9B – $4.3B
$6.3B
$6.0B – $6.6B
EPS
Growth Trends (YoY %)
Last updated: Jun 3, 2026 6:57pm (23d ago)
Metric 2022 2023 2024 2025
Revenue Growth +4.9% +9.6% +0.3% -9.8%
Gross Profit Growth +7.6% +3.8% +2.7% -13.5%
Operating Income Growth -3.8% -11.4% +6.7% -41.3%
Net Income Growth +5.6% -16.1% +12.4% -43.5%
EBITDA Growth -2.8% -9.9% +5.6% -37.0%
Insider Trading (Recent)
Last updated: Jun 3, 2026 6:57pm (23d ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-10 Alagirisamy Venkatesh F-InKind 9,853.00 $44.65 $439,936
2026-06-10 McCartney Philip F-InKind 9,836.00 $44.65 $439,177
2026-06-12 McCartney Philip S-Sale 17,398.00 $46.18 $803,440
2026-05-14 PARKER MARK G G-Gift 22,230.00 $0.00 $0
2026-04-13 Hill Elliott P-Purchase 23,660.24 $42.27 $1.0M
2026-04-13 Hill Elliott P-Purchase 23,660.24 $42.27 $1,000,000
2026-04-10 COOK TIMOTHY D P-Purchase 25,000.00 $42.43 $1.1M
2026-04-09 ROGERS JOHN W JR P-Purchase 4,000.00 $43.34 $173,360
2026-04-07 SWAN ROBERT HOLMES P-Purchase 11,781.39 $42.44 $500,002
2026-04-02 Knight Travis A J-Other 2,300,480.00 $0.00 $0
2026-04-02 Knight Travis A J-Other 2,300,480.00 $0.00 $0
2026-02-12 Leinwand Robert S-Sale 9,065.00 $62.33 $565,021
2026-02-11 KNIGHT PHILIP H G-Gift 4,500,000.00 $0.00 $0
2026-02-11 KNIGHT PHILIP H G-Gift 4,500,000.00 $0.00 $0
2026-02-10 Leinwand Robert F-InKind 4,647.00 $62.41 $290,019
2026-02-10 Heinle Treasure F-InKind 853.00 $62.41 $53,236
2026-02-02 KNIGHT PHILIP H C-Conversion 4,500,000.00 $0.00 $0
2026-02-02 KNIGHT PHILIP H C-Conversion 4,500,000.00 $0.00 $0
2025-12-31 Knight Travis A J-Other 3,000,000.00 $0.00 $0
2025-12-31 Knight Travis A J-Other 3,000,000.00 $0.00 $0
Dividend History (Last 20)
Last updated: Jun 3, 2026 6:51pm (23d ago)
Date Dividend Declaration Record Payment
2026-06-01 $0.41 2026-05-04 2026-06-01 2026-07-01
2026-03-02 $0.41 2026-02-13 2026-03-02 2026-04-01
2025-12-01 $0.41 2025-11-20 2025-12-01 2026-01-02
2025-09-02 $0.40 2025-08-07 2025-09-02 2025-10-01
2025-06-02 $0.40 2025-05-01 2025-06-02 2025-07-01
2025-03-03 $0.40 2025-02-13 2025-03-03 2025-04-01
2024-12-02 $0.40 2024-11-14 2024-12-02 2025-01-02
2024-09-03 $0.37 2024-08-01 2024-09-03 2024-10-01
2024-06-03 $0.37 2024-05-02 2024-06-03 2024-07-01
2024-03-01 $0.37 2024-02-08 2024-03-04 2024-04-01
2023-12-01 $0.37 2023-11-14 2023-12-04 2024-01-02
2023-09-01 $0.34 2023-08-03 2023-09-05 2023-10-02
2023-06-02 $0.34 2023-05-04 2023-06-05 2023-07-05
2023-03-03 $0.34 2023-02-09 2023-03-06 2023-04-03
2022-12-02 $0.34 2022-11-15 2022-12-05 2022-12-28
2022-09-02 $0.31 2022-08-04 2022-09-06 2022-10-03
2022-06-03 $0.31 2022-05-05 2022-06-06 2022-07-01
2022-03-04 $0.31 2022-02-10 2022-03-07 2022-04-01
2021-12-03 $0.31 2021-11-18 2021-12-06 2021-12-28
2021-08-27 $0.28 2021-08-05 2021-08-30 2021-10-01
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for NKE — it's generated by the pipeline (market-narrative step).
Delvantic AI Findings
Independent analyst synthesis · Delvantic - Cairn AI · generated 2026-06-18 22:22:38
Reviews the pipeline's own verdicts
Verdict Fairly valued with negative skew — fair value $40-55 range; the Feb'26 4.6% margin print says the bottom isn't in, wait for gross margin to stabilize above 43% before committing beyond a starter.

Looking at the raw quarterly tape first: revenue has gone from $12.61B (May'24) to $11.28B (Feb'26), a ~10% top-line erosion, but the more alarming line is net income — $1.50B collapsing to $520M in the most recent quarter, a 65% earnings compression on a 10% revenue decline. That's brutal operating deleverage and tells me gross margin and SG&A are both working against Nike simultaneously. Annual FY25 op income of $3.70B versus FY24's $6.31B (-41%) confirms this isn't noise. Gross margin slipped from ~45% historically to 42.7%, and operating margin from ~13% to ~8%. The TTM net margin of 6.95% is roughly half of Nike's historical 12-14% range. On the latest quarter annualized (~$45B rev, ~$2.5B NI), the stock trades at ~27x trough earnings and ~1.5x sales — neither obviously cheap nor obviously expensive for a franchise in decline.

The prior models are directionally aligned but I think they're soft-pedaling one thing: the Feb 2026 quarter shows margin getting *worse*, not better — 4.6% net margin is the lowest print in the series, below even the May'25 1.9% (which had one-time charges). The synthesis calls this "show me" pricing and Market Forces calls it "Market Headwinds," but the quarterly trajectory labeled "accelerating" in Revenue Confidence is misleading — revenue is seasonally lumpy (Nov is always the peak), and YoY comps are still negative across every recent quarter. I'd dissent from the "accelerating" tag; this is stabilization at a lower base at best. The Pre-Flight read of "traditional-in-transition" is the most honest framing — Nike is neither a compounder nor a turnaround yet, it's mid-fall with an unproven catch.

The contrarian case that nobody is making forcefully enough: Nike's competitive problem is qualitatively different from prior cycles. On Running and Hoka aren't fads — they've taken premium running share that Nike historically owned, and ASICS has reclaimed the performance runner. This isn't an inventory glut or a China cycle; it's brand fragmentation in the highest-margin category. If that's right, the right comp isn't Nike's own history at 30x — it's Under Armour or even Gap, where a structurally diminished brand trades at 0.8-1.2x sales and 12-15x normalized earnings. At 1x sales that's $46B market cap, or ~$31/share — 31% downside from here. The insider buying in April 2026 (multiple P-Purchases) is a genuine positive signal worth weighting — these are open-market buys, not 10b5-1 noise — but insiders have been wrong about brand turnarounds before (see: Intel). The 2.56% dividend yield gives you something to wait on, but FCF of $3.27B against a $3.0B+ dividend obligation means the payout is barely covered if margins don't recover.

I dissent mildly from the "Reasonable Premium" verdict — I think it's closer to fairly valued than premium, but only because the models are anchoring to depressed TTM earnings. On normalized earnings of ~$4.50-5.00B (assuming margins recover to 10%, halfway between current and peak), you get ~$3.10-3.40 EPS and a fair value of $55-65 at 18-20x. On the bear case (margins stay at 7%, revenue flat at $45B), normalized EPS is ~$2.00 and fair value is $30-36. Current $45 splits the difference, which is honest pricing for genuine uncertainty. I wouldn't buy here without seeing one clean quarter of YoY revenue growth AND gross margin stabilization above 43% — both are required, neither has happened. The insider buys would tempt me into a 1% starter only; the Feb'26 margin print tells me the bottom isn't in. The narrative durability call ("2-3 quarters to validate or kill") is exactly right — this is a stock to revisit after the next two prints, not to commit to today.

GPT Critique
Second-opinion review · gpt-4o · generated 2026-06-18 22:22:50
Reviews the Opus findings above
Verdict I agree with Opus — fairly valued at $45 with negative skew; I'd target fair value closer to $40-50, reflecting heightened competitive pressures and recent margin trends.

Nike's recent financial trajectory paints a concerning picture for a company that has long been a stalwart in the athletic apparel industry. The revenue decline from $51.36B in FY 2024 to $46.31B in FY 2025, coupled with a net income drop from $5.70B to $3.22B, indicates significant operational challenges. The consistent quarterly revenue and net income declines highlight not just cyclical issues but potential structural problems. The decline in gross margin from historical levels of 45% to 42.7% further underscores the pressure Nike is under, particularly in maintaining its pricing power amidst rising competition. These data points suggest a company grappling with both market dynamics and internal inefficiencies.

Opus argues that Nike's recent 4.6% net margin print is indicative of worsening conditions rather than improvement, a point I concur with given the sequential decline in margins over recent quarters. The narrative of a "traditional-in-transition" company aligns with what I observe; Nike is currently neither a compounder nor a clear turnaround story. The revenue and earnings CAGR rates, at -4.9% and -20.3% respectively, reinforce the notion of a business struggling to regain its footing in a competitive landscape. I agree with Opus that the market's "show me" pricing reflects skepticism, but I diverge on the assessment of "accelerating" revenue confidence as misleading. The recent YoY revenue declines don't support an accelerating trend, but rather suggest a stabilization at a diminished level.

I find Opus's skepticism about the competitive landscape particularly compelling. The rise of competitors like On Running and Hoka, combined with ASICS' resurgence, suggests a shift in consumer preferences that may not be easily reversible. This qualitative shift in the competitive environment could indeed justify a re-rating of Nike's stock akin to Under Armour or Gap, as opposed to its historical premium status. The significant insider purchases in April 2026 are a positive signal, yet, as Opus notes, they are not infallible indicators of a turnaround, especially in the face of such structural challenges.

A careful skeptic might argue that Nike's brand strength and global reach provide a buffer against these competitive pressures. They could point to the company's historically strong cash flow generation and the potential for strategic pivots or innovations to reinvigorate growth. However, the current data and competitive context suggest that such optimism should be tempered by the realities of the recent financial performance and market dynamics.

Community AI Feedback
No community reviews yet for NKE. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30